Search results
24 sty 2022 · Now, a study led by Stanford Medicine researchers has proved that the Epstein-Barr virus, a common type of herpes virus, triggers multiple sclerosis by priming the immune system to attack the body’s own nervous system.
23 lis 2022 · IN JANUARY 2022, Bjornevik and colleagues published the results of a 20-year prospective seroepidemiologic study on the relationship between Epstein-Barr virus (EBV) and multiple sclerosis (MS) in which investigators observed an enormous increase in the risk of MS after EBV infection.
7 lut 2023 · Large-scale genomic sequencing of EBV to search for pathogenic EBV variants associated with multiple sclerosis, and the study of the interactions between EBV and human genetics, will lead to a better understanding of EBV-induced disease mechanisms.
9 kwi 2024 · New study probes link between Epstein Barr, MS treatments. A team of researchers developed a new blood test to measure the immune response to the Epstein Barr Virus, which is the leading risk factor for developing multiple sclerosis.
The confirmation of a link between EBV and MS, however, now offers the opportunity to develop novel targeted treatments, from antivirals to cell-based therapies.
21 mar 2023 · Adoptive immunotherapy targeting Epstein–Barr virus has emerged as a potential therapeutic strategy for the treatment of multiple sclerosis. We have developed a novel manufacturing process, which can offer these T‐cell therapies as an off‐the‐shelf treatment. Introduction.
5 sie 2022 · We consider how knowledge of EBV-associated cancers may be instructive for understanding the role of EBV in MS and discuss the potential for therapies that target EBV to treat MS....
